Yahoo Web Search

Search results

1. • 

     3 Magnificent Stocks That Are Passive Income Machines

     Motley Fool via Yahoo Finance· 12 hours ago

     Find out why three Motley Fool contributors picked Eli Lilly (NYSE: LLY), AbbVie (NYSE: ABBV), and ...

2. • Analyst Report: Alcon Inc.

     Morningstar Research via Yahoo Finance· 2 hours ago

     Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates ...

3. • 2,145 Shares in Novartis AG (NYSE:NVS) Bought by Wealthcare Advisory Partners LLC

     ETF DAILY NEWS· 4 days ago

     Wealthcare Advisory Partners LLC bought a new stake in Novartis AG (NYSE:NVS – Free Report) during the fourth quarter, according to the company in its most recent Form 13F ...

4. • 

     Earnings call: Voyager Therapeutics advances Alzheimer's and gene therapy By Investing.com

     Investing.com· 13 hours ago

     With a partnership with Neurocrine (NASDAQ:NBIX) and a recent deal with Novartis (SIX:NOVN), Voyager...

5. • Novartis AG ADR (NVS) Stock: Analyzing the Market Value – News Heater

     NewsHeater· 5 days ago

     Novartis AG ADR (NYSE: NVS) has a higher price-to-earnings ratio of 13.52x compared to its average ratio, The 36-month beta value for NVS is at 0.58. The average trading volume ...

6. • 

     Exploring Dividend Stocks In Switzerland With Compagnie Financière Tradition And Two Others

     Simply Wall St. via Yahoo Finance· 18 hours ago

     Swiss stocks showed modest gains in a recent trading session, reflecting cautious investor sentiment...

7. • Novartis Gets FDA Breakthrough Therapy Designation for Scemblix

     Morningstar· 4 days ago

     Novartis said the U.S. drug regulator decided to expedite the development of Scemblix, to treat adults newly diagnosed with leukemia. The Swiss pharmaceutical company said ...

8. • 

     Drugmakers in Medicare Price Talks Spent Less on R&D Than on Shareholders, Marketing, Overhead:...

     The Fiscal Times via Yahoo Finance· 5 days ago

     The report says that the eight companies — Johnson & Johnson, Amgen, AstraZeneca, Bristol Myers...

9. • 

     FogPharma, Artbio join forces to design a different radiopharma drug

     BioPharma Dive via Yahoo Finance· 11 hours ago

     The biotechs aim to marry FogPharma’s polypeptide science with Artbio’s lead-based...

10. • 

      Jeremy Grantham's Strategic Moves in Q1 2024: A Closer Look at Alphabet Inc's Impact

      GuruFocus.com via Yahoo Finance· 8 hours ago

      The stock traded at an average price of $21.55 during the quarter and has seen a -26.63% return over...